Cargando…
Characterization of the Immune Infiltration Landscape and Identification of Prognostic Biomarkers for Esophageal Cancer
Immunotherapy is an effective treatment for esophageal cancer (ESCA) patients. However, there are no dependable markers for predicting prognosis and immunotherapy responses in ESCA. Our study aims to explore immune gene prognostic models and markers in ESCA as well as predictors for immunotherapy. T...
Autores principales: | Chen, Yuanmei, Huang, Xinyi, Chen, Lin, Weng, Guibin, Huang, Zhengrong, Zhang, Yangfan, Xiao, Tianya, Chen, Junqiang, Zhu, Kunshou, Xu, Yuanji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935668/ https://www.ncbi.nlm.nih.gov/pubmed/35780460 http://dx.doi.org/10.1007/s12033-022-00526-9 |
Ejemplares similares
-
LIMD2 is a Prognostic and Predictive Marker in Patients With Esophageal Cancer Based on a ceRNA Network Analysis
por: Chen, Yuanmei, et al.
Publicado: (2021) -
Tumor necrosis factor-related apoptosis-inducing ligand modulates angiogenesis and apoptosis to inhibit non-small cell lung carcinoma tumor growth in mice
por: Chen, Yuanmei, et al.
Publicado: (2019) -
Prognostic Value of SPOCD1 in Esophageal Squamous Cell Carcinoma: A Comprehensive Study Based on Bioinformatics and Validation
por: Lin, Zhizhong, et al.
Publicado: (2022) -
Primary gross tumor volume is prognostic and suggests treatment in upper esophageal cancer
por: Chen, Yuanmei, et al.
Publicado: (2021) -
Identification and validation of a prognostic signature of cuproptosis-related genes for esophageal squamous cell carcinoma
por: Zhang, Yiping, et al.
Publicado: (2023)